AZN Stock Summary and Trading Ideas (Astrazeneca PLC - American Depositary Shares | NASDAQ:AZN)

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.

Astrazeneca PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AZN.

As of December 13, 2024, AZN stock price declined to $66.58 with 3,076,201 million shares trading.

AZN has a beta of 0.07, meaning it tends to be less sensitive to market movements. AZN has a correlation of 0.00 to the broad based SPY ETF.

AZN has a market cap of $206.28 billion. This is considered a Mega Cap stock.

Last quarter Astrazeneca PLC - American Depositary Shares reported $14 billion in Revenue and $1.04 earnings per share. This beat revenue expectation by $475 million and exceeded earnings estimates by $.01.

In the last 3 years, AZN traded as high as $87.68 and as low as $52.65.

The top ETF exchange traded funds that AZN belongs to (by Net Assets): QQQ, QQQM, FVD, DIHP, DFIC.

AZN has underperformed the market in the last year with a price return of +6.3% while the SPY ETF gained +31.7%. AZN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.7% and -0.9%, respectively, while the SPY returned +8.4% and +0.9%, respectively.

AZN support price is $66.07 and resistance is $67.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AZN shares will trade within this expected range on the day.